1250 related articles for article (PubMed ID: 24481842)
1. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.
Yang X; Pabon L; Murry CE
Circ Res; 2014 Jan; 114(3):511-23. PubMed ID: 24481842
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.
Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS
Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428
[TBL] [Abstract][Full Text] [Related]
3. Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes.
Sun X; Nunes SS
Methods; 2016 May; 101():21-6. PubMed ID: 26546730
[TBL] [Abstract][Full Text] [Related]
4. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
Tan SH; Ye L
J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
[TBL] [Abstract][Full Text] [Related]
5. Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells:
Jiang Y; Park P; Hong SM; Ban K
Mol Cells; 2018 Jul; 41(7):613-621. PubMed ID: 29890820
[TBL] [Abstract][Full Text] [Related]
6. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
[TBL] [Abstract][Full Text] [Related]
7. Learn from Your Elders: Developmental Biology Lessons to Guide Maturation of Stem Cell-Derived Cardiomyocytes.
Marchianò S; Bertero A; Murry CE
Pediatr Cardiol; 2019 Oct; 40(7):1367-1387. PubMed ID: 31388700
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.
Karbassi E; Fenix A; Marchiano S; Muraoka N; Nakamura K; Yang X; Murry CE
Nat Rev Cardiol; 2020 Jun; 17(6):341-359. PubMed ID: 32015528
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.
Denning C; Borgdorff V; Crutchley J; Firth KS; George V; Kalra S; Kondrashov A; Hoang MD; Mosqueira D; Patel A; Prodanov L; Rajamohan D; Skarnes WC; Smith JG; Young LE
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1728-48. PubMed ID: 26524115
[TBL] [Abstract][Full Text] [Related]
10. Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo.
Gomez-Garcia MJ; Quesnel E; Al-Attar R; Laskary AR; Laflamme MA
Semin Cell Dev Biol; 2021 Oct; 118():163-171. PubMed ID: 34053865
[TBL] [Abstract][Full Text] [Related]
11. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
Ban K; Bae S; Yoon YS
Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
[TBL] [Abstract][Full Text] [Related]
12. Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes.
Ge F; Wang Z; Xi JJ
Cells; 2019 Dec; 9(1):. PubMed ID: 31861463
[TBL] [Abstract][Full Text] [Related]
13. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics Identifies Metabolic Markers of Maturation in Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Bhute VJ; Bao X; Dunn KK; Knutson KR; McCurry EC; Jin G; Lee WH; Lewis S; Ikeda A; Palecek SP
Theranostics; 2017; 7(7):2078-2091. PubMed ID: 28656061
[TBL] [Abstract][Full Text] [Related]
15. Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes.
Keung W; Boheler KR; Li RA
Stem Cell Res Ther; 2014 Jan; 5(1):17. PubMed ID: 24467782
[TBL] [Abstract][Full Text] [Related]
16. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.
Zhu R; Blazeski A; Poon E; Costa KD; Tung L; Boheler KR
Stem Cell Res Ther; 2014 Oct; 5(5):117. PubMed ID: 25688759
[TBL] [Abstract][Full Text] [Related]
17. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
Hodonsky C; Wu K; Mundada L; Si MS
Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
[TBL] [Abstract][Full Text] [Related]
18. Tumor Suppressors RB1 and CDKN2a Cooperatively Regulate Cell-Cycle Progression and Differentiation During Cardiomyocyte Development and Repair.
Hatzistergos KE; Williams AR; Dykxhoorn D; Bellio MA; Yu W; Hare JM
Circ Res; 2019 Apr; 124(8):1184-1197. PubMed ID: 30744497
[TBL] [Abstract][Full Text] [Related]
19. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
Tiburcy M; Hudson JE; Balfanz P; Schlick S; Meyer T; Chang Liao ML; Levent E; Raad F; Zeidler S; Wingender E; Riegler J; Wang M; Gold JD; Kehat I; Wettwer E; Ravens U; Dierickx P; van Laake LW; Goumans MJ; Khadjeh S; Toischer K; Hasenfuss G; Couture LA; Unger A; Linke WA; Araki T; Neel B; Keller G; Gepstein L; Wu JC; Zimmermann WH
Circulation; 2017 May; 135(19):1832-1847. PubMed ID: 28167635
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.
Dick E; Rajamohan D; Ronksley J; Denning C
Biochem Soc Trans; 2010 Aug; 38(4):1037-45. PubMed ID: 20659000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
